December 12, 2016

The marketers of a mobile app designed to measure blood pressure have agreed to settle FTC charges that they deceived consumers with claims that their Instant Blood Pressure app was as accurate as a traditional blood pressure cuff. In addition, the Commission alleged that the owner provided a positive review of the app, rating it “five stars” in the app stores, without disclosing his connection to the company. Under the terms of the FTC settlement, Aura Labs, Inc., doing business as AuraLife and AuraWare, and its founder and co-owner, Ryan Archdeacon, are barred from making such unsupported claims in the future and must disclose any material connections between Aura and people who endorse its products. FTC

Tagged in: Antitrust Enforcement, Misrepresentations,